In a filing, Matson Inc revealed its VP and Controller STUCK KEVIN L unloaded Company’s shares for reported $49085.0 on Jun 04 ’25. In the deal valued at $113.10 per share,434 shares were sold. As a result of this transaction, STUCK KEVIN L now holds 3,016 shares worth roughly $0.33 million.
Then, TILDEN BRADLEY D bought 2,752 shares, generating $307,564 in total proceeds. Upon buying the shares at $111.76, the Director now owns 8,180 shares.
Before that, Isotoff Leonard P sold 500 shares. Matson Inc shares valued at $55,736 were divested by the Senior Vice President at a price of $111.47 per share. As a result of the transaction, Isotoff Leonard P now holds 5,644 shares, worth roughly $0.62 million.
Jefferies initiated its Matson Inc [MATX] rating to a Buy in a research note published on April 29, 2025; the price target was $125. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid November from “an Outperform” to “a Peer perform”. Wolfe Research also remained covering MATX and has increased its forecast on October 04, 2023 with a “an Outperform” recommendation from previously “Peer perform” rating. Wolfe Research revised its rating on November 17, 2022. It rated MATX as “a Peer perform” which previously was an “an Underperform”.
Price Performance Review of MATX
On Tuesday, Matson Inc [NYSE:MATX] saw its stock fall -1.64% to $110.03. Over the last five days, the stock has lost -3.51%. Matson Inc shares have fallen nearly -18.40% since the year began. Nevertheless, the stocks have fallen -9.20% over the past one year. While a 52-week high of $169.12 was reached on 02/26/25, a 52-week low of $91.75 was recorded on 05/07/25.
Levels Of Support And Resistance For MATX Stock
The 24-hour chart illustrates a support level at 109.26, which if violated will result in even more drops to 108.49. On the upside, there is a resistance level at 111.57. A further resistance level may holdings at 113.11.
The most recent change occurred on August 16, 2022 when Wolfe Research began covering the stock and recommended ‘”an Underperform”‘ rating along with a $80 price target.
